SARS-CoV-2 susceptibility and COVID-19 illness course and outcome in people with pre-existing neurodegenerative disorders: Systematic review with frequentist and …

M Smadi, M Kaburis, Y Schnapper, G Reina… - The British Journal of …, 2023 - cambridge.org
BackgroundPeople with neurodegenerative disease and mild cognitive impairment (MCI)
may have an elevated risk of acquiring severe acute respiratory syndrome coronavirus 2 …

A significant predictor of in‐hospital and long‐term mortality and progression in COVID‐19 patients: The end‐stage liver disease (MELD) score model

Y Kaya, O Gülcü, E Aksakal, K Kalkan… - Journal of medical …, 2023 - Wiley Online Library
The aim of this study is to investigate the relationship between the model for end‐stage liver
disease (MELD) score and disease progression and mortality in COVID‐19 patients. The …

Predictors of mortality for patients with COVID-19 in the rural Appalachian region

H Bhopalwala, N Dewaswala, S Kolagatla… - … Journal of General …, 2022 - Taylor & Francis
Background The prevalence and outcome of coronavirus disease 2019 (COVID-19) in rural
areas is unknown. Methods This is a multi-center retrospective cohort study of hospitalized …

Hepatic dysfunctions in COVID-19 patients infected by the omicron variant of SARS-CoV-2

J Zhang, D Zhao, J Hu, X Huang, Q Gu… - Frontiers in Public …, 2022 - frontiersin.org
Background Presently, the omicron variant of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) dominates amid the coronavirus disease 2019 (COVID-19) …

A nationwide study of liver disease hospitalizations during the coronavirus pandemic in the United States

M Sedarous, M Youssef, AD Adekunle… - Journal of …, 2023 - Wiley Online Library
Abstract Background and Aim The impact of the Coronavirus disease‐2019 (COVID‐19)
pandemic on patients with liver disease is not well described at the population level in the …

Nervous system involvement in hospitalized patients with COVID-19: Clinical and laboratory associations with poorer outcomes

MH Harirchian, M Ghabaee, P Sarraf… - Infectious Diseases in …, 2024 - journals.lww.com
Background COVID-19 patients with neurological manifestations have poorer outcomes. We
investigated the association between clinicodemographic and laboratory findings with …

Patient health records and whole viral genomes from an early SARS-CoV-2 outbreak in a Quebec hospital reveal features associated with favorable outcomes

B Paré, M Rozendaal, S Morin, L Kaufmann… - Plos one, 2021 - journals.plos.org
The first confirmed case of COVID-19 in Quebec, Canada, occurred at Verdun Hospital on
February 25, 2020. A month later, a localized outbreak was observed at this hospital. We …

[HTML][HTML] The Model for End-Stage Liver Disease (MELD) Score Predicting Mortality Due to SARS-CoV-2 in Mexican Patients

JM Reyes-Ruiz, AC Avelino-Santiago… - Journal of Clinical …, 2024 - mdpi.com
Background/Objectives: Coronavirus Disease 2019 (COVID-19) can cause liver injury and a
deterioration of hepatic function. The Model for End-Stage Liver Disease (MELD) score is a …

[HTML][HTML] Outcomes of heart failure in COVID-19 patients: an Appalachian experience

H Bhopalwala, A Akbar, N Dewaswala… - Cardiology …, 2022 - ncbi.nlm.nih.gov
Background The Southeastern rural areas of the USA have a higher prevalence of heart
failure (HF). Coronavirus disease 2019 (COVID-19) infection is associated with poor …

Liver injury in COVID-19: prevalence and its associated factors in Nepal–A retrospective cross-sectional study

B Rajbhandari, S Pant, AB Hamal… - Annals of Medicine …, 2023 - journals.lww.com
Background: Liver impairment has been reported as a common clinical manifestation in
patients with Severe Acute Respiratory Syndrome Coronavirus 2 infection, with varying …